Skip to main content
SpringerLink
Log in

Treatment of Acute Headaches

  • Chapter
Headache

Part of the book series: Clinical Medicine and the Nervous System ((CLIN.MED.NERV.))

  • 70 Accesses

Abstract

The majority of patients with occasional attacks of headache are best managed with medication intended to suppress each as it arises. Drugs used for the prevention of recurrent disabling headaches of the migraine or tension types are discussed in detail in the next chapter, and any treatment available specifically for the cause of the pain—for example steroids for temporal arteritis, or surgery for cerebral tumour—must not be overlooked. Clearly, analgesic medication should be offered to all patients complaining of headache unless the response to a specific remedy is considered in itself to be of diagnostic value.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Ala-Hurula V (1982) Bioavailability and antimigraine efficacy of effervescent ergotamine. Headache 22: 167–170

    Article  PubMed  CAS  Google Scholar 

  • Ala-Hurula V, Myllyla VV, Arvela Pet al. (1979) Systemic availability of ergotamine tartrate after oral, rectal and intramuscular administration. Eur J Clin Pharmacol 15: 51–55

    Article  PubMed  CAS  Google Scholar 

  • Ala-Hurula V, Myllyla VV, Hokkanen E (1982) Ergotamine abuse: results of ergotamine discontinuation, with special reference to the plasma concentrations. Cephalalgia 2: 189–195

    Article  PubMed  CAS  Google Scholar 

  • Anthony M, Lance JW (1968) Indomethacin in migraine. Med J Aust 1: 56–57

    PubMed  CAS  Google Scholar 

  • Baldrati A, Cortelli P, Procaccianti G et al. (1983) Propranolol and acetylsalicylic acid in migraine prophylaxis. Acta Neurol Scand 67: 181–186

    Article  PubMed  CAS  Google Scholar 

  • Boardman PL, Dudley Hart F (1967) Side-effects of indomethacin. Ann Rheum Dis 26: 127–132

    Article  PubMed  CAS  Google Scholar 

  • Costall B, Gunning SJ, Naylor RJ et al. (1983) A central site of action for benzamide facilitation of gastric emptying. Eur J Pharmacol 91: 197–205

    Article  PubMed  CAS  Google Scholar 

  • Crooks J, Stephen SA, Brass W (1964) Clinical trial of inhaled ergotamine tartrate in migraine. Br Med J I: 221–224

    Google Scholar 

  • Diamond S (1976) Treatment of migraine with isometheptene, acetaminophen, and dichloralphenazone combination: a double-blind, crossover trial. Headache 15: 282–287

    Article  PubMed  CAS  Google Scholar 

  • Diamond S (1983) Ibuprofen versus aspirin and placebo in the treatment of muscle contraction headache. Headache 23: 206–210

    Article  PubMed  CAS  Google Scholar 

  • Dudley HW, Moir C (1935) The substance responsible for the traditional clinical effect of ergot. Br Med J I: 520–523

    Google Scholar 

  • Ekbom K, Krabbe A, Paalzow G et al. (1983) Optimal routes of administration of ergotamine tartrate in cluster headache patients. A pharmacokinetic study. Cephalalgia 3: 15–20

    Google Scholar 

  • Eulenburg A (1883) Subcutane Injectionen von Ergotinin (Tanret) = Ergotininum citricum solutum (Gehe). Dtsch Med Wochenschr 9: 637–639

    Google Scholar 

  • Featherstone HJ (1983) Low-dose propranolol therapy for aborting migraine. West J Med 138: 416–417

    PubMed  CAS  Google Scholar 

  • Flower RJ, Vane JR (1972) Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidophenol). Nature 240: 410–411

    Article  PubMed  CAS  Google Scholar 

  • Fozard JR (1975) The animal pharmacology of drugs used in the treatment of migraine. J Pharm Pharmacol 27: 297–321

    Article  PubMed  CAS  Google Scholar 

  • Fozard JR (1984) MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Arch Pharmacol 326: 36–44

    Article  CAS  Google Scholar 

  • Fozard JR (1985) 5-Hydroxytryptamine in the pathophysiology of migraine. Proceedings of the Fifth International Congress on Vascular Neuroeffector Mechanisms. Paris, 6–8 August 1984. Elsevier, Amsterdam, pp 321–328

    Google Scholar 

  • General Practitioner Clinical Research Group (1973) Migraine treated with an antihistamine-analgesic combination. Practitioner 211: 357–361

    Google Scholar 

  • Geraud G, Guell A, Courtade M et al. (1983) Clinical value of a dopaminergic agonist administration in migraine patients. Headache 23: 191–192

    Article  PubMed  CAS  Google Scholar 

  • Gilbert MM, de Sola Pool N, Schecter C (1976) Analgesic/calmative effects of acetaminophen and phenyltoloxamine in treatment of simple nervous tension accompanied by headache. Curr Ther Res 20: 53–58

    CAS  Google Scholar 

  • Graffenried B v, Hill RC (1978) Headache as a model for testing mild analgesics. Res Clin Stud Headache 6: 103–109

    PubMed  Google Scholar 

  • Graham JR, Wolff HG (1938) Mechanism of migraine headache and action of ergotamine tartrate. Arch Neurol Psychiatry 39: 737–763

    CAS  Google Scholar 

  • Hakkarainen H, Vapaatalo H, Gothoni G et al. (1979) Tolfenamic acid is as effective as ergotamine during migraine attacks. Lancet II: 326–328

    Google Scholar 

  • Hall DW (1968) Migraine: mefenamic acid (Ponstan) in the treatment of attacks. J R Coll Gen Pract 15: 321–324

    PubMed  CAS  Google Scholar 

  • Harrington RA, Hamilton CW, Brogden RN et al. (1983) Metoclopramide: an updated review of its pharmacological properties and clinical use. Drugs 25: 451–494

    Article  PubMed  CAS  Google Scholar 

  • Hovdal H, Syversen GB, Rosenthaler J (1982) Ergotamine in plasma and CSF after i.m. and rectal administration to humans. Cephalalgia 2: 145–150

    Article  PubMed  CAS  Google Scholar 

  • Iserson KV (1983) Parenteral chlorpromazine treatment of migraine. Ann Emerg Med 12: 756–758

    Article  PubMed  CAS  Google Scholar 

  • Johnson ES, Ratcliffe DM, Wilkinson M (1985) Naproxen sodium in the treatment of migraine. Cephalalgia 5: 5–10

    Article  PubMed  CAS  Google Scholar 

  • Kuehl FA, Egan RW (1980) Prostaglandins, arachidonic acid, and inflammation. Science 210: 978–984

    Article  PubMed  CAS  Google Scholar 

  • Lasagna L, Davis M, Pearson JW (1967) A comparison of acetophenetidin and acetaminophen 1. Analgesic effects in postpartum patients. J Pharmacol Exp Ther 155: 296–300

    Google Scholar 

  • Lee P, Anderson JA, Miller J et al. (1976) Evaluation of analgesic action and efficacy of antirheumatic drugs. J Rheumatol 3: 283–294

    PubMed  CAS  Google Scholar 

  • Leopold NA (1984) Prolonged metoclopramide-induced dyskinetic reaction. Neurology 34: 238–239

    PubMed  CAS  Google Scholar 

  • Lippman CW (1955) Characteristic headache resulting from prolonged use of ergot derivatives. J Nerv Ment Dis 121: 270–273

    Article  PubMed  CAS  Google Scholar 

  • Mamvura CB (1983) Migraine headache: the prophylactic role of an isopyrin-phebuzine compound (Tomanol). Central African J Med 29: 200–201

    CAS  Google Scholar 

  • Mikkelsen BM, Falk JV (1982) Prophylactic treatment of migraine with tolfenamic acid. Acta Neurol Scand 66: 105–111

    Article  PubMed  CAS  Google Scholar 

  • Muller-Schweinitzer E, Fanchamps A (1982) Effects on arterial receptors of ergot derivatives used in migraine. Adv Neurol 33: 343–356

    PubMed  CAS  Google Scholar 

  • O’Neill BP, Mann JD (1978) Aspirin prophylaxis in migraine. Lancet II: 1179–1181

    Google Scholar 

  • Orton DA, Richardson RJ (1982) Ergotamine absorption and toxicity. Postgrad Med J 58: 6–11

    Article  PubMed  CAS  Google Scholar 

  • Ostfeld AM (1961) A study of migraine pharmacotherapy. Am J Med Sci 241: 192–198

    Article  PubMed  CAS  Google Scholar 

  • Pearce I, Frank GJ, Pearce JMS (1983) Ibuprofen compared with paracetamol in migraine. Practitioner 227: 465–467

    PubMed  CAS  Google Scholar 

  • Peatfield RC, Petty RG, Clifford Rose F (1983) Double blind comparison of mefenamic acid and acetaminophen (paracetamol) in migraine. Cephalalgia 3: 129–134

    Article  PubMed  CAS  Google Scholar 

  • Peatfield RC, Petty RG, Clifford Rose F (1983) Double blind comparison of mefenamic acid and acetaminophen (paracetamol) in migraine. Cephalalgia 3: 129–134

    Article  PubMed  CAS  Google Scholar 

  • Reasbeck PG, Rice ML, Reasbeck JC (1982) Double-blind controlled trial of indomethacin as an adjunct to narcotic analgesia after major abdominal surgery. Lancet II: 115–117

    Google Scholar 

  • Ross-Lee L, Heazlewood V, Tyrer JH et al. (1982) Aspirin treatment of migraine attacks: plasma drug level data. Cephalalgia 2: 9–14

    Article  PubMed  CAS  Google Scholar 

  • Ryan RE (1974) A study of midrin in the symptomatic relief of migraine headache. Headache 14: 33–42

    Article  PubMed  CAS  Google Scholar 

  • Sacks W (1980) The use of an isopyrine-phenylbutazone compound in migraine. SA Med J 58: 444–446

    CAS  Google Scholar 

  • Saxena PR, Koedam NA, Heiligers J et al. (1983) Ergotamine-induced constriction of cranial arteriovenous anastomoses in dogs pretreated with phentolamine and pizotifen. Cephalagia 3: 71–81

    Article  CAS  Google Scholar 

  • Schulze-Delrieu K (1981) Metoclopramide. N Engl J Med 305: 28–33

    Article  PubMed  CAS  Google Scholar 

  • Spierings ELH, Saxena PR (1980) Effect of isometheptene on the distribution and shunting of 15 µM microspheres throughout the cephalic circulation of the cat. Headache 20: 103–106

    Article  PubMed  CAS  Google Scholar 

  • Stensrud P, Sjaastad O (1974) Clinical trial of a new anti-bradykinin anti-inflammatory drug ketoprofen (19.583 R.P.) in migraine prophylaxis. Headache 14: 96–100

    Article  PubMed  CAS  Google Scholar 

  • Sutherland JM, Hooper WD, Eadie MJ et al. (1974) Buccal absorption of ergotamine. J Neurol Neurosurg Psychiatry 37: 1116–1120

    Article  PubMed  CAS  Google Scholar 

  • Tell GP, Fozard JR, Schecter PJ et al. (1984) Controlled study of MDL 72,222, an antagonist at neuronal 5-HT receptors, in the symptomatic treatment of migraine. Br J Clin Pharmacol 18: 279 P

    Google Scholar 

  • Tfelt-Hansen P, Olesen J (1980) Paracetamol (acetaminophen) versus acetylsalicyclic acid in migraine. Eur Neurol 19: 163–165

    Article  PubMed  CAS  Google Scholar 

  • Tfelt-Hansen P, Eickhoff JH, Olesen J (1980) The effect of single dose ergotamine tartrate on peripheral arteries in migraine patients: methodological aspects and time effect curve. Acta Pharmacol Toxicol (Copenh) 47: 151–156

    Article  CAS  Google Scholar 

  • Tfelt-Hansen P, Paalzow L, Ibraheem JJ (1982) Bioavailability of sublingual ergotamine. Br J Clin Pharmacol 13: 239–240

    PubMed  CAS  Google Scholar 

  • Tfelt-Hansen P, Ibraheem JJ, Paalzow L (1982) Clinical pharmacology of ergotamine studied with a high-performance liquid chromatographic method. In: Clifford Rose F (ed) Advances in migraine research and therapy. Raven, New York, pp 173–179

    Google Scholar 

  • Thomson WH (1894) Ergot in the treatment of periodic neuralgias. J Nerv Ment Dis 19: 124–126 Tokola R, Hokkanen E ( 1978 ) Propranolol for acute migraine. Br Med J II: 1089

    Google Scholar 

  • Tokola RA, Kangasniemi P, Neuvonen PJ et al. (1984) Tolfenamic acid, metoclopramide, caffeine and their combinations in the treatment of migraine attacks. Cephalalgia 4: 253–263

    Article  PubMed  CAS  Google Scholar 

  • Vardi Y, Rabey IM, Streifler M et al. (1976) Migraine attacks. Alleviation by an inhibitor of prostaglandin synthesis and action. Neurology 26: 447–450

    Google Scholar 

  • Volans GN (1974) Absorption of effervescent aspirin during migraine. Br Med J 4: 265–269

    Article  PubMed  CAS  Google Scholar 

  • Volans GN (1975) The effect of metoclopramide on the absorption of effervescent aspirin in migraine. Br J Clin Pharmacol 2: 57–63

    PubMed  CAS  Google Scholar 

  • Waters WE (1970) Controlled clinical trial of ergotamine tartrate. Br Med J II: 325–327

    Article  Google Scholar 

  • Waelkens J (1982) Domperidone in the prevention of complete classical migraine. Br Med J 284: 944

    Article  CAS  Google Scholar 

  • Wainscott G, Volans G, Wilkinson M (1974) Ergotamine-induced headaches. Br Med J II: 724

    Article  Google Scholar 

  • Wainscott G, Kaspi T, Volans GN (1976) The influence of thiethylperazine on the absorption of effervescent aspirin in migraine. Br J Clin Pharmacol 3: 1015–1021

    CAS  Google Scholar 

  • Welch KMA, Ellis D, Keenan PA (1985) Successful migraine prophylaxis with naproxen sodium. Neurology 35: 1304–1310

    PubMed  CAS  Google Scholar 

  • Woakes E (1868) On ergot of rye in the treatment of neuralgia. Br Med II: 360–361

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. General Infirmary at Leeds, Great George Street, Leeds 1, West Yorkshire, UK

    Richard Peatfield MA, MD, MRCP (Senior Registrar-Neurology)

Authors
  1. Richard Peatfield MA, MD, MRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Peatfield, R. (1986). Treatment of Acute Headaches. In: Headache. Clinical Medicine and the Nervous System. Springer, London. https://doi.org/10.1007/978-1-4471-3127-4_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-3127-4_10

  • Publisher Name: Springer, London

  • Print ISBN: 978-3-540-19531-3

  • Online ISBN: 978-1-4471-3127-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation